Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Radeleff, B; Schawo, S; Hoffmann, K; Schemmer, P; Noeldge, G; Kauffmann, GW; Froehlich, B; Richter, GM.
Efficacy and safety of percutaneous transhepatic portal embolization before right liver resection using an ethibloc/lipiodol mixture: a single-center experience.
Dig Surg. 2008; 25(1):52-59 Doi: 10.1159/000118795
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Schemmer Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The purpose of this study was to evaluate the safety and efficacy of percutaneous transhepatic portal vein embolization of the right portal vein with an Ethibloc/Lipiodol mixture to induce hypertrophy of the left liver lobe in patients with primarily unresectable liver tumor. 15 patients (8 primary liver tumors, 7 liver metastases) underwent portal vein embolization. Liver volumetry, duration of hospitalization, complication rates, relevant laboratory values were documented. In 13/15 patients (84.6%) embolization could be performed with a median of 8.8 ml (range 1.5-28 ml) Ethibloc/Lipiodol. One minor procedure-related complication (subcapsular hematoma) occurred, which did not affect the two-step liver resection. No patient developed acute liver failure after embolization or liver resection. The volume of the left liver lobe increased significantly (p = 0.0015) by 25% from a median of 750 ml (587-1,114 ml) to 967 ml (597-1,249 ml). 11/13 (81.8%) of the embolized patients underwent liver resection at a median of 49 days after embolization. Median hospitalization time was 4 days after embolization and 7 days after liver resection. Median overall survival of the 11 operated patients was 376 days. Percutaneous transhepatic portal vein embolization using an Ethibloc/Lipiodol mixture is a safe, feasible, and efficient interventional procedure.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Aged -
Diatrizoate - administration & dosage
Drug Combinations -
Embolization, Therapeutic -
Fatty Acids - administration & dosage
Female -
Hepatectomy -
Humans -
Iodized Oil - administration & dosage
Liver Regeneration -
Male -
Middle Aged -
Portal Vein -
Propylene Glycols - administration & dosage
Prospective Studies -
Sclerosing Solutions - administration & dosage
Treatment Outcome -
Zein - administration & dosage

Find related publications in this database (Keywords)
portal vein
angiography
embolization
ethibloc
liver resection
liver metastases
© Med Uni GrazImprint